Actelion Pharmaceuticals Ltd - Company Profile

Powered by

All the data and insights you need on Actelion Pharmaceuticals Ltd in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Actelion Pharmaceuticals Ltd Strategy Report

  • Understand Actelion Pharmaceuticals Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Actelion Pharmaceuticals Ltd: Overview

Select Item

Actelion Pharmaceuticals Ltd (Actelion), a subsidiary of Johnson & Johnson, is a biopharmaceutical company, which discovers, develops and commercializes innovative treatments for diseases with considerable unmet medical needs. The company focuses on the development of treatments for pulmonary arterial hypertension (PAH). Its PAH franchise products include Tracleer (bosentan), Opsumit (macitentan), Veletri (epoprostenol for injection), Ventavis (iloprost)\, and Uptravi (selexipag). Its specialty product includes Zavesca (miglustat). Actelion also offers approved treatments for diseases including Type 1 Gaucher disease, Niemann-Pick type C disease, multiple sclerosis and digital ulcers in patients with systemic sclerosis. The company offers its products in various countries across Europe, besides Japan, China, Russia, and the US, among others. Actelion is headquartered in Allschwil, Switzerland.

 Gain a 360-degree view of Actelion Pharmaceuticals Ltd and make more informed decisions for your business Gain a 360-degree view of Actelion Pharmaceuticals Ltd and make more informed decisions for your business Find out more
Headquarters Switzerland
Address Gewerbestrasse 16, Allschwil, Basel-Landschaft, 4123
Website www.actelion.com
Telephone 41 61 5656565
Industry Pharmaceuticals and Healthcare
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Actelion Pharmaceuticals Ltd premium industry data and analytics

260+

Clinical Trials

Determine Actelion Pharmaceuticals Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

70+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Actelion Pharmaceuticals Ltd’s relevant decision makers and contact details.

50+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

40+

Catalyst Calendar

Proactively evaluate Actelion Pharmaceuticals Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

40+

Pipeline Drugs

Identify which of Actelion Pharmaceuticals Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

7

Marketed Drugs

Understand Actelion Pharmaceuticals Ltd’s commercialized product portfolio to stay one step ahead of the market.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Actelion Pharmaceuticals Ltd (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

Products and Services

Products Brands
Tracleer (bosentan) Tracleer
Ventavis (iloprost) Ventavis
Opsumit (macitentan) Opsumit
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Actelion Pharmaceuticals Ltd portfolio and identify potential areas for collaboration Understand Actelion Pharmaceuticals Ltd portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Actelion Pharmaceuticals Ltd F. Hoffmann-La Roche Ltd Santhera Pharmaceuticals Holding AG Mymetics Corp Alpex Pharma SA
Headquarters Switzerland Switzerland Switzerland Switzerland Switzerland
City Allschwil Basel Pratteln Epalinges Mezzovico
State/Province Basel-Landschaft - - - Tessin
No. of Employees - 103,605 46 8 -
Entity Type Private Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Andre C. Muller Executive Vice President; Chief Financial Officer Senior Management 2013 58
Nicholas Franco Chief Business Development Officer; Executive Vice President Senior Management 2011 57
Alessandro Maresta Head - Medical Affairs; Vice President Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Actelion Pharmaceuticals Ltd key executives to enhance your sales strategy Gain insight into Actelion Pharmaceuticals Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward